Skip to main content

Table 3 Newly additional medications after the allocation

From: The effect of dapagliflozin treatment on epicardial adipose tissue volume

 

Dapagliflozin (n = 20)

Conventional therapy (n = 20)

SGLT-2 inhibitor

20 (100)

0

α-GI

0 (0)

3 (15)

DPP-4 inhibitor

0 (0)

14 (70)

Biguanide

0 (0)

1 (5)

Sulfonyl urea

0 (0)

1 (5)

Glinide

0 (0)

1 (5)

Pioglitazone

0 (0)

0

  1. Data are presented as the number (percentage)
  2. SGLT-2 sodium-glucose co-transporter-2, α-GI α-glucosidase inhibitors, DPP-4 dipeptidyl peptidase-4